Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis

International Urology and Nephrology

Volumn 41, Issue 4, 2009, Pages 959-966

  Khaira, Ambar ^a   Gupta, Ankur ^a   Rana, Devendra S ^b   Gupta, Ashwini ^b   Bhalla, Anil ^b   Khullar, Dinesh ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b SIR GANGA RAM HOSPITAL   (India)

Author keywords

Diabetes mellitus; Dialysis; Emphysematous pyelonephritis; Nephrectomy; Percutaneous drainage

Indexed keywords

AMPHOTERICIN B; CARBAPENEM DERIVATIVE; CEFEPIME; CEFPIROME; CEFTIZOXIME; CEFTRIAXONE; COLISTIN; CREATININE; IMIPENEM; INSULIN; MEROPENEM; METRONIDAZOLE; TEICOPLANIN;

ACINETOBACTER; ADULT; ARTICLE; BACTERIUM CULTURE; BACTEROIDES FRAGILIS; CANDIDA TROPICALIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DISEASE CLASSIFICATION; DISSEMINATED INTRAVASCULAR CLOTTING; EMPHYSEMATOUS PYELONEPHRITIS; ESCHERICHIA COLI; FEMALE; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; KLEBSIELLA; MALE; NEPHRECTOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCUTANEOUS DRAINAGE; PERITONEAL DIALYSIS; PROGNOSIS; PROTEUS MIRABILIS; PYELONEPHRITIS; RETROSPECTIVE STUDY; SEPSIS; SHOCK;

ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DRAINAGE; EMPHYSEMA; ESCHERICHIA COLI INFECTIONS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; KLEBSIELLA INFECTIONS; MALE; MIDDLE AGED; NEPHRECTOMY; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PYELONEPHRITIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; URINALYSIS;

EID: 77954564065     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9552-y     Document Type: Article

References (26)

1. Huang JJ, Tseng CC (2000) Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 27:797-805. doi: 10.1001/archinte.160.6.797
2. Tang HJ, Li CM, Yen MY et al (2001) Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect 34:125-130
3. Modi P, Goel R, Dodia S (2007) Scrotal extension of emphysematous pyelonephritis 2007. Int Urol Nephrol 40:405-407. doi: 10.1007/s11255-006-9018-4 (Pubitemid 47054834)
4. Baliga KV, Narula AS, Sharma A et al (2007) Successful medical treatment of emphysematous pyelonephritis in a renal allograft recipient. Ren Fail 29:755-758. doi: 10.1080/08860220701460434 (Pubitemid 47346990)
5. Chuang YW, Chen CH, Cheng CH et al (2007) Severe emphysematous pyelonephritis in a renal allograft: successful treatment with percutaneous drainage and antibiotics. Clin Nephrol 68:42-46
6. Fujita S, Watanabe J, Reed AI et al (2005) Case of emphysematous pyelonephritis in a renal allograft. Clin Transplant 19:559-562. doi: 10.1111/j.1399-0012.2005. 00264.x
7. Kalra OP, Malik N, Minz M et al (1993) Emphysematous pyelonephritis and cystitis in a renal transplant recipientcomputed tomographic appearance. Int J Artif Organs 16:41-44
8. Schultz EH, Klorfein EH (1962) Emphysematous pyelonephritis. J Urol 87:762-766
9. Kamaliah MD, Bhajan MA, Dzarr GA (2005) Emphysematous pyelonephritis caused by Candida infection. Southeast Asian J Trop Med Public Health 36:725-727
10. Hildebrand TS, Nibbe L, Frei U et al (1999) Bilateral emphysematous pyelonephritis caused by Candida infection. Am J Kidney Dis 33:E10. doi: 10.1016/S0272-6386 (99)70331-8
11. Sultana SR, McNeill SA, Phillips G et al (1998) Candidal urinary tract infection as a cause of pneumaturia. J R Coll Surg Edinb 43:198-199
12. Seidenfeld SM, Lemaistre CF, Setiawan H et al (1982) Emphysematous pyelonephritis caused by Candida tropicalis. J Infect Dis 146:569
13. Wu VC, Fang CC, Li WY et al (2004) Candida tropicalisassociated bilateral renal papillary necrosis and emphysematous pyelonephritis. Clin Nephrol 62:473-475
14. Wan YL, Lo SK, Bullard MJ et al (1998) Predictors of outcome in Emphysematous pyelonephritis. J Urol 159: 369-373. doi: 10.1016/S0022-5347(01) 63919-3 (Pubitemid 28049235)
15. Ramachandran A, Snehalatha C, Kapur A et al (2001) High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44:1094-1101. doi: 10.1007/s001250100627 (Pubitemid 32835500)
16. Dutta P, Bhansali A, Singh SK et al (2007) Presentation and outcome of emphysematous renal tract disease in patients with diabetes mellitus. Urol Int 78:13-22. doi: 10.1159/000096929 (Pubitemid 46034181)
17. Shokeir AA, El-Azab M, Mohsen T et al (1997) Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology 49:343-346. doi: 10.1016/S0090-4295(96) 00501-8
18. Ahlering TE, Boyd SD, Hamilton CL et al (1985) Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol 134:1086-1088
19. Soo Park B, Lee SJ, Wha Kim Y et al (2006) Outcome of nephrectomy and kidney-preserving procedures for the treatment of emphysematous pyelonephritis. Scand J Urol Nephrol 40:332-338
20. Arun N, Hussain A, Kapoor MM et al (2007) Bilateral emphysematous pyelonephritis and emphysematous cystitis with autosomal-dominant polycystic kidney disease: is conservative management justified? Med Princ Pract 16:155-157. doi: 10.1159/000098371
21. Shimizu H, Hariu K, Kamiyama Y et al (1999) Bilateral emphysematous pyelonephritis with autosomal-dominant polycystic kidney disease successfully treated by conservative method. Urol Int 63:252-254. doi: 10.1159/000030 462
22. Somani BK, Nabi G, Thorpe P et al (2008) ABACUS Research Group is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol 179:1844-1849. doi: 10.1016/j.juro.2008.01.019
23. Liao HW, Chen TH, Lin KH et al (2005) Emphysematous pyelonephritis caused by Bacteroides fragilis. Nephrol Dial Transplant 20:2575-2577. doi: 10.1093/ndt/gfi146 (Pubitemid 41548897)
24. Tolwani AJ, Wheeler TS, Wille KM (2007) Sustained lowefficiency dialysis. Contrib Nephrol 156:320-324. doi: 10.1159/000102122
25. Edwards SJ, Clarke MJ, Wordsworth S et al (2008) Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials. Eur J Clin Microbiol Infect Dis 27:531-543. doi: 10.1007/s10096-008-0472-z
26. Baldwin CM, Lyseng-Williamson KA, Keam SJ (2008) Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs 68:803-838. doi: 10.2165/ 00003495-200868060-00006